UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk

Breast cancer research and treatment, 2016-09, Vol.159 (2), p.327-333

2016

Volltextzugriff (PDF)

Summary of head‐to‐head comparisons of patient risk classifications by the 21‐gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer

International journal of cancer, 2019-08, Vol.145 (4), p.882-893

2019

Volltextzugriff (PDF)

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Journal of clinical oncology, 2008-04, Vol.26 (10), p.1642-1649

2008

Volltextzugriff (PDF)

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer

Current medical research and opinion, 2021-07, Vol.37 (7), p.1179-1187

2021

Volltextzugriff (PDF)

Evolving HER2+ Metastatic Breast Cancer Landscape

Oncology (Williston Park, N.Y.), 2021-12, Vol.35 (12), p.839

2021

Volltextzugriff (PDF)

Randomized, Controlled Trial of Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients

Journal of clinical oncology, 2007-12, Vol.25 (35), p.5584-5590

2007

Volltextzugriff (PDF)

Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Journal of clinical oncology, 2012-01, Vol.30 (1), p.88-109

2012

Volltextzugriff (PDF)

Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis

NPJ breast cancer, 2023-10, Vol.9 (1), p.86-86, Article 86

2023

Volltextzugriff (PDF)

A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer

Clinical cancer research, 2008-12, Vol.14 (23), p.7878-7883

2008

Volltextzugriff (PDF)

Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Journal of clinical oncology, 2010-12, Vol.28 (36), p.5327-5347

2010

Volltextzugriff (PDF)

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab

NPJ breast cancer, 2022-03, Vol.8 (1), p.37-37, Article 37

2022

Volltextzugriff (PDF)

New strategies for the treatment of breast cancer with leptomeningeal metastasis

Current opinion in oncology, 2023-11, Vol.35 (6), p.500-506

2023

Volltextzugriff (PDF)

Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis

Clinical breast cancer, 2017-02, Vol.17 (1), p.23-28

2017

Volltextzugriff (PDF)

Author's reply to: Comparing the performance of gene expression assays in breast cancer

International journal of cancer, 2019-08, Vol.145 (4), p.1163-1164

2019

Volltextzugriff (PDF)

The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury?

Current oncology reports, 2011-02, Vol.13 (1), p.17-25

2011

Volltextzugriff (PDF)

Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis

Journal of clinical oncology, 2022-11, Vol.40 (33), p.3858-3867

2022

Volltextzugriff (PDF)

Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes

European journal of cancer (1990), 2024-08, Vol.207, p.114175, Article 114175

2024

Volltextzugriff (PDF)

Comparative Effectiveness Research Needs to Consider Optimal Dosing and Scheduling

Journal of clinical oncology, 2021-01, Vol.39 (3), p.253-254

2021

Volltextzugriff (PDF)

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients

European journal of cancer (1990), 2018-09, Vol.101, p.12-19

2018

Volltextzugriff (PDF)

Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases

Clinical cancer research, 2019-07, Vol.25 (13), p.3784-3792

2019

Volltextzugriff (PDF)

Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2010-02, Vol.28 (4), p.628-633

2010

Volltextzugriff (PDF)

Clinical trial of proton craniospinal irradiation for leptomeningeal metastases

Neuro-oncology (Charlottesville, Va.), 2021-01, Vol.23 (1), p.134-143

2021

Volltextzugriff (PDF)

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study

Neuro-oncology (Charlottesville, Va.), 2015-02, Vol.17 (2), p.289-295

2015

Volltextzugriff (PDF)

When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

Oncology (Williston Park, N.Y.), 2016-03, Vol.30 (3), p.224-228

Seidman, Andrew D

2016

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Englisch
(234)

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(143)
Humans
(140)
Female
(108)
Oncology
(105)
Breast Neoplasms - Drug Therapy
(79)
Middle Aged
(70)
Adult
(63)
Aged
(54)
Biological And Medical Sciences
(50)
Medical Sciences
(49)
Breast Neoplasms - Pathology
(48)
Breast Cancer
(43)
Chemotherapy
(39)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(36)
Pharmacology. Drug Treatments
(36)
Antineoplastic Agents
(35)
Tumors
(29)
Treatment Outcome
(28)
Male
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk

Summary of head‐to‐head comparisons of patient risk classifications by the 21‐gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer

Evolving HER2+ Metastatic Breast Cancer Landscape

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases

Randomized, Controlled Trial of Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients

Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis

A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer

Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab

New strategies for the treatment of breast cancer with leptomeningeal metastasis

Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis

Author's reply to: Comparing the performance of gene expression assays in breast cancer

The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury?

Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis

Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes

Comparative Effectiveness Research Needs to Consider Optimal Dosing and Scheduling

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients

Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases

Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Clinical trial of proton craniospinal irradiation for leptomeningeal metastases

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study

When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

Suchergebnisse filtern